open access
Adrenal venous sampling as a method of primary hyperaldosteronism assessment
, 2
Affiliations- University Clinical Hospital in Wroclaw, Department of Nephrology and Transplant Medicine, 213 Borowska, 50-556 Wroclaw, Poland
- University Clinical Hospital in Wroclaw, Department of Rheumatology and Internal Medicine, 213 Borowska, 50-556 Wroclaw, Poland
open access
Abstract
We read with great interest the article by Orczyk et. al which discussed an unusual presentation and clinical course of primary hyperaldosteronism, which is frequently caused by Conn’s syndrome. Inspired by their engrossing work, we would like to address a diagnostic method that has not been employed in the aforecited case report despite accumulating evidence of its efficacy, called adrenal venous sampling.
Abstract
We read with great interest the article by Orczyk et. al which discussed an unusual presentation and clinical course of primary hyperaldosteronism, which is frequently caused by Conn’s syndrome. Inspired by their engrossing work, we would like to address a diagnostic method that has not been employed in the aforecited case report despite accumulating evidence of its efficacy, called adrenal venous sampling.
Keywords
primary hyperaldosteronism, adrenal venous sampling, adrenal tumour, computed tomography
About this articleTitle
Adrenal venous sampling as a method of primary hyperaldosteronism assessment
Journal
Issue
Article type
Letter to the Editor
Pages
193-195
Published online
2023-08-23
Page views
226
Article views/downloads
234
DOI
Bibliographic record
Arterial Hypertension 2023;27(3):193-195.
Keywords
primary hyperaldosteronism
adrenal venous sampling
adrenal tumour
computed tomography
Authors
Ugo Sławomir Giordano
Jakub Kobiałka
References (10)- Orczyk J, Ołownia A, Gałązka J, et al. nonspecific clinical picture and the course of Conn syndrome — current findings in the screening program for hypertensive patients. Arterial Hypertens. 2023.
- Yang YH, Chang YL, Lee BC, et al. Strategies for subtyping primary aldosteronism. J Formos Med Assoc. 2023 [Epub ahead of print].
- Hundemer GL, Curhan GC, Yozamp N, et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018; 6(1): 51–59.
- Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018; 6(1): 41–50.
- Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001; 86(3): 1066–1071.
- Rossi GP, Funder JW. Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Pro Side of the Argument. Hypertension. 2018; 71(1): 5–9.
- Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014; 63(1): 151–160.
- Naruse M, Katabami T, Shibata H, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022; 69(4): 327–359.
- Zhou Y, Wang D, Jiang L, et al. Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis. BMJ Open. 2020; 10(12): e038489.
- Rossi GP, Crimì F, Rossitto G, et al. Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study. J Clin Endocrinol Metab. 2021; 106(11): e4340–e4349.